UPDATED: AstraZeneca rejects Pfizer's improved final bid
Pfizer’s sweetened bid to acquire AstraZeneca for £55, up from £50 per share, has been rejected. - News - PharmaTimes
by Katrina Megget and Kevin Grogan
https://www.pharmatimes.com/news/updated_astrazeneca_rejects_pfizers_improved_final_bid_1001958